- Home
- TELO
as 07-26-2024 4:00pm EST
Stocks
Telomir Pharmaceuticals Inc is a pre-clinical-stage pharmaceutical company focused on the development and commercialization of TELOMIR-1, a novel small molecule being developed to function as an oral in situ therapeutic treatment for human stem cells.
| Founded: | 2021 | Country: | United States |
| Employees: | N/A | City: | TAMPA |
| Market Cap: | 165.2M | IPO Year: | 2024 |
| Target Price: | N/A | AVG Volume (30 days): | 52.0K |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.64 | EPS Growth: | N/A |
| 52 Week Low/High: | $3.51 - $20.72 | Next Earning Date: | 08-12-2024 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Stock Insider Trading Activity of TELOMIR PHARMACEUTICALS INC (TELO)
| Name | Ticker | Relationship | Date | Transaction | Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Bay Shore Trust | TELO | 10% Owner | Feb 13 '24 | Buy | $7.00 | 49,000 | $343,000.00 | 5,455,431 | SEC Form 4 |
| Bay Shore Trust | TELO | 10% Owner | Feb 13 '24 | Buy | $7.00 | 40,000 | $280,000.00 | 1,365,646 | SEC Form 4 |
| Bay Shore Trust | TELO | 10% Owner | Feb 13 '24 | Buy | $7.00 | 49,000 | $343,000.00 | 1,902,659 | SEC Form 4 |
Latest TELOMIR PHARMACEUTICALS INC News
TELO Breaking Stock News: Dive into TELO Ticker-Specific Updates for Smart Investing
MT Newswires
24 days ago
Telomir Pharmaceuticals Joins Russell 3000, Microcap Indexes
GlobeNewswire
24 days ago
Telomir Pharmaceuticals Added to Membership of Russell 3000 and Russell Microcap Indexes
GlobeNewswire
a month ago
Telomir Pharmaceuticals Scientific Advisor to Participate in Drug Information Association 2024 Global Annual Meeting Panel
The Telegraph
2 months ago
Italian energy company targets Britain for fleet of 20 mini-nukes
Simply Wall St.
2 months ago
It Might Not Be A Great Idea To Buy StepStone Group LP (NASDAQ:STEP) For Its Next Dividend
Simply Wall St.
2 months ago
Is Now The Time To Put Planet Fitness (NYSE:PLNT) On Your Watchlist?
Simply Wall St.
2 months ago
Don't Buy Banc of California, Inc. (NYSE:BANC) For Its Next Dividend Without Doing These Checks
Motley Fool
2 months ago
4 Reasons to Buy Invesco QQQ Trust Like There's No Tomorrow
Compare TELO vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "TELO TELOMIR PHARMACEUTICALS INC - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.